February 24, 2010 -- San Diego -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today announced that it will report its operating results for the fourth quarter and all of fiscal 2009 on Wednesday, March 3.
The company will hold a conference call to discuss its financial results and operating activities open to all interested parties at 2 p.m., Pacific Standard Time, (5 p.m., Eastern Standard Time), Wednesday, March 3, hosted by Scott Huennekens, president and chief executive officer, and John Dahldorf, chief financial officer.
The teleconference can be accessed by calling (719) 325-4867, passcode 6208547. Please dial in 10-15 minutes prior to the beginning of the call. The webcast will be available through the company's website at www.volcanocorp.com.
A replay of the conference call will be available through Wednesday, March 10, at (719) 457-0820, passcode 6208547, and via the company's website.
About Volcano Corporation
Volcano Corporation (Nasdaq: VOLC) offers a broad
suite of devices designed to facilitate endovascular procedures, enhance the
diagnosis of vascular and structural heart disease and guide optimal therapies.
The company's intravascular ultrasound (IVUS) product line includes ultrasound
consoles that can be integrated directly into virtually any modern cath lab.
Volcano IVUS offers unique features, including both single-use digital and
rotational IVUS imaging catheters, and advanced functionality options, such
as VH® IVUS tissue characterization and ChromaFlo®. Volcano also provides
functional measurement (FM) consoles and single-use pressure and flow guide
wires and is developing a line of ultra-high resolution Optical Coherence Tomography
(OCT) systems and catheters. Currently, more than 4,700 Volcano IVUS and FM
systems are installed worldwide, and more than half of Volcano's revenues are
derived from outside the United States. Volcano's wholly-owned subsidiary,
Axsun Technologies, develops and manufactures optical monitors, lasers and
optical engines used in telecommunications, medical imaging, spectroscopy and
other industrial applications. For more information, visit the company's website
at www.volcanocorp.com.
(Disclaimer: external
links to news, press releases and other timely information
sources are provided as a service by Angioplasty.Org, which
is not responsible for the content found on any external
sites. Items marked with a ($$) indicate that the external
site normally restricts viewing to paid subscribers. Other
sites may require free registration.
